scholarly article | Q13442814 |
P50 | author | Maree Smith | Q24851696 |
Jason A. Roberts | Q38544404 | ||
Adrian G. Barnett | Q38590672 | ||
Yoke Lin Fung | Q50648552 | ||
Kiran Shekar | Q58396529 | ||
Steven C Wallis | Q58397119 | ||
P2093 | author name string | John F Fraser | |
Daniel V Mullany | |||
Sussan Ghassabian | |||
Charles I Mcdonald | |||
Stephanie Fisquet | |||
P2860 | cites work | Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates | Q30310834 |
Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. | Q30410342 | ||
Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients | Q33824276 | ||
Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients | Q34052619 | ||
Pharmacokinetics in the newborn | Q35111481 | ||
Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. | Q35124226 | ||
Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation | Q35826801 | ||
Antibiotic resistance--what's dosing got to do with it? | Q37205795 | ||
Pharmacokinetic issues for antibiotics in the critically ill patient | Q37399820 | ||
Pharmacokinetics and pharmacodynamics in critically ill patients | Q37758059 | ||
Antibiotic dosing in multiple organ dysfunction syndrome | Q37871704 | ||
Sedation and analgesia in the mechanically ventilated patient | Q37948029 | ||
Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation | Q38004165 | ||
Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure | Q38027639 | ||
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients | Q39487652 | ||
Determinants of drug absorption in different ECMO circuits. | Q42362818 | ||
Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. | Q43060269 | ||
Stability of meropenem and doripenem solutions for administration by continuous infusion | Q43153667 | ||
Sedative clearance during extracorporeal membrane oxygenation | Q46857795 | ||
Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactions. | Q47623151 | ||
Sedation during extracorporeal membrane oxygenation-why more is less | Q48111467 | ||
High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS. | Q48142980 | ||
In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. | Q51417979 | ||
Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. | Q51938979 | ||
Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? | Q58812745 | ||
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story | Q64129476 | ||
Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs | Q72595886 | ||
Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment | Q80089048 | ||
Current status of extracorporeal life support (ECMO) for cardiopulmonary failure | Q84543309 | ||
P433 | issue | 5 | |
P921 | main subject | extracorporeal membrane oxygenation | Q1385195 |
P304 | page(s) | R194 | |
P577 | publication date | 2012-10-15 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation | |
P478 | volume | 16 |